Latest Articles

Publication Date
Karyopharm completes endometrial cancer trial enrollment - Investing.com

Karyopharm completes endometrial cancer trial enrollment Investing.com

Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment By Investing.com - Investing.com Canada

Karyopharm completes endometrial cancer trial enrollment By Investing.com Investing.com Canada

Published: May 14, 2026, 11:45 a.m.
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M - Stock Titan

Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M Stock Titan

Published: May 14, 2026, 11:30 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire

Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire

Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo

Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo

Published: May 14, 2026, 11:30 a.m.
Endometriosis: A silent growing condition affecting women - Daily Monitor

Endometriosis: A silent growing condition affecting women Daily Monitor

Published: May 14, 2026, 9:08 a.m.
‘I don’t want other girls to go through this’: Co Derry woman who waited 10 years for endometriosis diagnosis on tackling period poverty - The Irish News

‘I don’t want other girls to go through this’: Co Derry woman who waited 10 years for endometriosis diagnosis on tackling period poverty The Irish News

Published: May 14, 2026, 5 a.m.
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer - OncLive

Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer OncLive

Published: May 14, 2026, 12:06 a.m.
Preliminary Evaluation of Leuprorelin Acetate Microspheres Plus Levonorgestrel-Releasing Intrauterine System in Endometriosis: An Exploratory Study Focusing on BNIP3 and EPAC1 Expression.

This exploratory pilot study aimed to assess the preliminary clinical effects of leuprorelin acetate microspheres for injection [gonadotropin-releasing hormone agonist (GnRH-a)] combined with levonorgestrel-releasing intrauterine system (LNG-IUS) in treating endometriosis …

Published: May 14, 2026, midnight
The impact of different energy sources on redox balance during endometriotic cyst laparoscopy.

The aim of the study was to follow the impact of cystectomy and compare bipolar and laser electrocoagulation on prooxidative stress biomarkers and antioxidative capacity. A total of 60 women …

Published: May 14, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!